Navigation Links
ADVENTRX Settles Dispute With Former Licensee
Date:6/30/2008

SAN DIEGO, June 30 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: ANX) today announced that it settled its dispute with Theragenex, LLC and its Chairman and President and Chief Executive Officer for payments aggregating $600,000, which payments the Company has received in full. The parties have agreed to jointly move to dismiss the underlying arbitration action and all related claims and counterclaims, with prejudice. In addition, in connection with dismissing the arbitration, the Company and Theragenex will release each other from any and all claims related to their past relationship.

In October 2007, the Company filed a demand for arbitration against Theragenex (doing business as TRx Pharma, LLC and/or TRx Pharmaceuticals, LLC) and its founder, Chairman and President and Chief Executive Officer in his individual capacity as the alter ego of Theragenex, seeking damages of up to $10 million with respect to breach of a license agreement, dated October 20, 2006, between the Company and Theragenex. In November 2007, Theragenex responded to the Company's demand, asserting numerous affirmative defenses, counterclaiming intentional misrepresentation, negligent misrepresentation and rescission and seeking a refund of its initial $500,000 payment under the license agreement, plus interest, rescission of the license agreement and that the Company pay its reasonable attorneys' fees and costs associated with the action.

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates primarily for the treatment of cancer and infectious disease. The Company seeks to improve the performance and commercial po
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
2. ADVENTRX Appoints Vice President of Manufacturing
3. ADVENTRX Creates Executive Vice President Position and Announces New Chief Financial Officer
4. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
5. ADVENTRX Pharmaceuticals to Report Fourth Quarter and Year End 2007 Results
6. Eric K. Rowinsky Joins ADVENTRX Board of Directors
7. ADVENTRX to Present Complete ANX-530 Pharmacokinetic Data at the 2008 American Association for Cancer Research Annual Meeting
8. ADVENTRX Announces Consolidation of Clinical and Management Positions
9. ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results
10. ADVENTRX Appoints Vice President of Commercialization
11. ADVENTRX Pharmaceuticals to Present at the 2007 BIOInvestor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Canada (PRWEB) January 15, 2014 ... regulatory perspectives on nonclinical and clinical safety assessment ... countries to guide a path for biosimilar drug ... the demonstration of biosimilarity with regards to quality, ... specific aspects of biosimilar drug development and registration, ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains ... of these latent viruses is the Epstein Barr Virus ... (RA). Rheumatoid arthritis (RA) is a chronic inflammatory disease ... theory, a study found that RA patients have high ... , What is Microcompetition? , Dr. Hanan Polansky discovered ...
(Date:1/15/2014)... ON (PRWEB) January 15, 2014 ... Therapy, an experimental new therapy for the treatment of ... tailor-made for their unique tinnitus frequency, and over a ... , AudioNotch has previously provided Notched Sound Therapy in ... AudioNotch is pleased to announce to release of a ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine ... cells grown under simulated embryonic conditions, today announced ... agreement with Suneva Medical, Inc. for physician-dispensed aesthetic ... (CCM). , This agreement is an ... Suneva Medical, through which Suneva has exclusively licensed ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... Based on the clinical success,of its facet replacement ... has expanded its executive management team and established,its ... Massachusetts,allows us to consolidate our operations in one ... gives us access to a wealth of,talent in ...
... Winners of 2008 R&D 100 Awards Now Online, ... the,finalists for the 8th Annual Innovator of the Year ... individuals who exemplify the,ideals of R&D in academia, industry, ... facilitated online with ten finalists,-- five scientists and five ...
... pleased to announce that Dr. Francis Stoessel, a leading ... will be the Keynote Speaker in the Process Safety ... ... Columbia, MD (PRWEB) October ...
Cached Biology Technology:Facet Solutions Establishes Corporate Headquarters and Expands Executive Team 22008 R&D Innovator of the Year & Scientist of the Year Finalists Announced 2
(Date:4/15/2014)... nanoparticle form could help reduce side effects by targeting ... scientists have developed nanoparticles that deliver one or two ... design particles that can carry any more than that ... devised a new way to build such nanoparticles, making ... drugs. In a paper published in the Journal ...
(Date:4/15/2014)... become clear that the genetic code is far ... the well-known building blocks adenine, cytosine, guanine, and ... Scientists now assume that the newly discovered nucleic ... information that extends and complements the genetic code. ... extend the standard alphabet," explained Professor Mark Helm ...
(Date:4/15/2014)... Rosemont, IL (April 15, 2014) New research ... Journal of the American College of Nutrition shows ... exercise or as part of a weight-loss or weight-maintenance ... body composition. , The meta-analysis included 14 randomized ... When researchers analyzed those weight loss studies that used ...
Breaking Biology News(10 mins):Targeting cancer with a triple threat 2Targeting cancer with a triple threat 3German Research Foundation approves new priority program in the life sciences 2New meta-analysis builds on the power of whey protein for improved body composition 2New meta-analysis builds on the power of whey protein for improved body composition 3
... Terrace, Ill., March 8, 2010 Americans recognize things need ... Sam,s efforts to overhaul what is included in their food ... are individually responsible for making the right food choices to ... be successful, according to a new survey by FoodMinds. ...
... the fractious debate on the existence of God and ... the discussion. Taking a perspective rooted in evolutionary biology ... (Prometheus Books, $25) renowned anthropologist Lionel Tiger and pioneering ... is its purpose? How did it arise? What is ...
... problems have to be fed intravenously. There moreover, exist systems ... Mr Iaki Irastorza, paediatrician at the Cruces hospital in Bilbao, ... children were treated at the Great Ormond Street Children,s Hospital ... highly novel PhD thesis at the University of the Basque ...
Cached Biology News:Americans want Uncle Sam's help putting healthy foods on their dinner table 2Which came first: Religion or the brain? 2First time research on long-term consequences of intravenous nutrition on children's health 2First time research on long-term consequences of intravenous nutrition on children's health 3
... analysis kit for 10 chips provides the ... analysis with the Experion automated electrophoresis system. ... 3 x 520 microliters Pro260 gel, 45 ... (10-260 kD), 400 microliters Pro260 sample buffer, ...
... original Gene Pulser apparatus and accessory modules the ... in the Gene Pulser II system, which features ... Gene Pulser II system has the dual advantages ... range of settings to target specific cell types ...
Experion Pro260 chips are the microfluidic chips used to perform protein analysis with the Experion automated electrophoresis system. Each chip has the capacity to run 10 protein samples. Supplied as...
... Pro260 reagents and supplies, for 10 ... sufficient to perform protein analysis with ... electrophoresis system. Supplied are 3 x ... Pro260 stain, 60 microliters Pro260 ladder ...
Biology Products: